{
    "clinical_study": {
        "@rank": "75666", 
        "acronym": "Resolution", 
        "arm_group": {
            "arm_group_label": "behavioral weight loss and exercise", 
            "arm_group_type": "Experimental", 
            "description": "weight loss and exercise lifestyle intervention over a 6 month period"
        }, 
        "brief_summary": {
            "textblock": "This is a study of the effects of weight loss and exercise training on glucose control as\n      measured by the Hemoglobin A 1 C in individuals with recently diagnosed Type 2 Diabetes.\n      Study outcomes are measured at 6 months.  The primary outcome is the HBA1c at 6-months.\n      Secondary outcomes include body weight, fitness, lipid profiles and HS-CRP, a measure of\n      inflammation.  The study hypothesis is that the program of weight loss and exercise will put\n      >50% of individuals into \"remission\" of their type 2 Diabetes as measured by a HBA1c of <\n      6.5%."
        }, 
        "brief_title": "Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Weight Loss"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a study of the effects of weight loss and exercise training on glucose control as\n      measured by the Hemoglobin A 1 C in individuals with recently diagnosed Type 2 Diabetes.\n      Study outcomes are measured at 6 months.  The primary outcome is the HBA1c at 6-months.\n      Secondary outcomes include body weight, fitness, lipid profiles and HS-CRP, a measure of\n      inflammation.  The study hypothesis is that the program of weight loss and exercise will put\n      >50% of individuals into \"remission\" of their type 2 Diabetes as measured by a HBA1c of <\n      6.5%.\n\n      The study replicates the clinical situation where selected patients with new type 2\n      diabetes, who are motivated to try an intensive lifestyle intervention, might replicate our\n      study intervention if we are able to show a high remission rate (e.g. > 50%) for individuals\n      in the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  new diagnosis of type 2 diabetes since 12 months\n\n          -  BMI>27\n\n          -  HBA1c > 6.5,  , 8.0\n\n        Exclusion Criteria:\n\n          -  HBA1c >8.0\n\n          -  BMI< 27"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065544", 
            "org_study_id": "CHRMS: M11-198"
        }, 
        "intervention": {
            "arm_group_label": "behavioral weight loss and exercise", 
            "description": "Weight loss and exercise counseling", 
            "intervention_name": "behavioral weight loss and exercise", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 2 diabetes mellitus", 
            "behavioral weight loss", 
            "exercise training", 
            "hemoglobin A1c"
        ], 
        "lastchanged_date": "February 18, 2014", 
        "number_of_arms": "1", 
        "official_title": "Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise", 
        "overall_official": {
            "affiliation": "University of Vermont", 
            "last_name": "Philip A Ades, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "HBA1c was the primary outcome as a measure of glucose control in individuals with recently diagnosed type 2 diabetes.", 
            "measure": "Hemoglobin A1c", 
            "safety_issue": "No", 
            "time_frame": "6-months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065544"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Vermont", 
            "investigator_full_name": "Philip Ades", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "A lipid profile will be drawn before, and after the 6 month intervention", 
                "measure": "lipid profile", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "A HS-C Reactive Protein will be drawn before and after the 6 month intervention.", 
                "measure": "HS-C Reactive Protein", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Aerobic fitness will be measured as Peak Vo2 on the treadmill before and after the 6 month intervention", 
                "measure": "Aerobic Fitness", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "University of Vermont", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Vermont", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}